Cases & Deals

  • Home
  • Practices
  • Infinity establishes global patent portfolio for small molecule inhibitors of FAAH

Share

Infinity establishes global patent portfolio for small molecule inhibitors of FAAH

November 2010

Client(s) Infinity Pharmaceuticals, Inc.

Jones Day assists Infinity Pharmaceuticals, Inc. in the establishment of a global patent portfolio related to small molecule inhibitors of fatty acid amide hydrolase (FAAH).

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.